Cargando…
In Silico Model Estimates the Clinical Trial Outcome of Cancer Vaccines
Over 30 years after the first cancer vaccine clinical trial (CT), scientists still search the missing link between immunogenicity and clinical responses. A predictor able to estimate the outcome of cancer vaccine CTs would greatly benefit vaccine development. Published results of 94 CTs with 64 ther...
Autores principales: | Lőrincz, Orsolya, Tóth, József, Molnár, Levente, Miklós, István, Pántya, Kata, Megyesi, Mónika, Somogyi, Eszter, Csiszovszki, Zsolt, Tőke, Enikő R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616443/ https://www.ncbi.nlm.nih.gov/pubmed/34831269 http://dx.doi.org/10.3390/cells10113048 |
Ejemplares similares
-
A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects
por: Somogyi, Eszter, et al.
Publicado: (2021) -
T cell immunity ameliorates COVID-19 disease severity and provides post-exposure prophylaxis after peptide-vaccination, in Syrian hamsters
por: Somogyi, Eszter, et al.
Publicado: (2023) -
Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study
por: Hubbard, Joleen M., et al.
Publicado: (2022) -
Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer’s Disease: From In Silico to In Vivo
por: Stern, Noa, et al.
Publicado: (2022) -
Single DermaVir Immunization: Dose-Dependent Expansion of Precursor/Memory T Cells against All HIV Antigens in HIV-1 Infected Individuals
por: Lisziewicz, Julianna, et al.
Publicado: (2012)